Liver cirrhosis and sepsis study
Part of Infections clinical trials.
This study is for people with both cirrhosis and sepsis. It will follow their hospital course to better understand how these two conditions affect each other, which may help improve care for others in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cirrhosis (a condition where the liver is scarred and damaged).
- You meet the Sepsis-3 criteria, which means you have a suspected or confirmed infection along with signs that your body's organs are struggling (such as low blood pressure or confusion).
- You have not had an organ transplant and do not have an active cancer.
- You are not pregnant or breastfeeding.
- You are not on long-term immunosuppressant medications other than steroids.
- You are expected to stay in the hospital for more than 24 hours after admission (not discharged or passing away within that time).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body's genes respond in liver failure and sepsis to better understand these conditions and potentially improve treatment.
This study looks at how sepsis (a severe infection that affects the whole body) can damage the liver in children. It may help doctors understand and detect liver problems early, so they can provide better care for children with sepsis.
This study looks at how gut bacteria change in people with liver cirrhosis and whether these changes relate to how the disease progresses. It may help find new ways to monitor or treat cirrhosis.
This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This study is exploring a new way to predict how liver cirrhosis will progress. It may help doctors better understand and manage the condition.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.